• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions.

作者信息

Pavlidis Antonis N, Jones Daniel A, Sirker Alex, Mathur Anthony, Smith Elliot J

机构信息

Department of Cardiology, London Chest Hospital, Barts Health NHS Trust, London, United Kingdom.

Department of Cardiology, London Chest Hospital, Barts Health NHS Trust, London, United Kingdom.

出版信息

Am J Cardiol. 2015 Mar 15;115(6):844-51. doi: 10.1016/j.amjcard.2014.12.047. Epub 2015 Jan 6.

DOI:10.1016/j.amjcard.2014.12.047
PMID:25638517
Abstract

Chronic total occlusions (CTOs) represent a major challenge in percutaneous coronary revascularization. The recent advances in strategies and techniques and the development of dedicated equipment, such as microcatheters and wires, have resulted in considerably higher success rates. Although successful CTO recanalization is associated with significant clinical benefits, including improvement of angina, quality of life, reduced need for surgical revascularization, and improvement of left ventricular function, CTO procedures may require prolonged x-ray exposure and use of larger volumes of contrast compared with non-CTO procedures. Large volumes of contrast medium have been associated with increased rates of contrast-induced acute kidney injury (CI-AKI) and adverse short- and long-term outcomes. Application of specific measures and algorithms should be considered by all CTO operators to prevent CI-AKI.

摘要

相似文献

1
Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions.
Am J Cardiol. 2015 Mar 15;115(6):844-51. doi: 10.1016/j.amjcard.2014.12.047. Epub 2015 Jan 6.
2
[Percutaneous treatment of coronary chronic total occlusions: state of the art].经皮冠状动脉慢性完全闭塞病变的治疗:现状
G Ital Cardiol (Rome). 2017 Jun;18(6 Suppl 1):3S-11S. doi: 10.1714/2718.27729.
3
Improved cardiac survival, freedom from MACE and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions.经皮冠状动脉慢性完全闭塞血管再通治疗后,心脏存活率提高,主要不良心血管事件和心绞痛相关生活质量改善。
Int J Cardiol. 2012 Nov 1;161(1):31-8. doi: 10.1016/j.ijcard.2011.04.023. Epub 2011 Jul 1.
4
Recanalization of Chronic Total Occlusions in Patients With vs Without Chronic Kidney Disease: The Impact of Contrast-Induced Acute Kidney Injury.慢性完全闭塞病变患者与非慢性肾脏病患者的再通:对比剂诱导急性肾损伤的影响。
Can J Cardiol. 2018 Oct;34(10):1275-1282. doi: 10.1016/j.cjca.2018.07.012. Epub 2018 Jul 19.
5
A rationale for chronic total coronary occlusion revascularization: an evidence-based review of clinical trials.慢性完全性冠状动脉闭塞血管重建的理论依据:基于证据的临床试验综述
J Invasive Cardiol. 2004 Feb;16 Suppl B:3-6.
6
[Percutaneous coronary intervention for chronic total occlusion: clinical perspectives in 2015].[经皮冠状动脉介入治疗慢性完全闭塞病变:2015年临床视角]
Rev Med Suisse. 2015 May 27;11(476):1172-9.
7
Revascularization of chronic total occlusions: time to reconsider?慢性完全闭塞病变的血运重建:是时候重新考虑了吗?
J Am Coll Cardiol. 2014 Sep 23;64(12):1281-9. doi: 10.1016/j.jacc.2014.06.1181.
8
A case of CTO treated with minimum use of contrast media.CTO 病变采用最少对比剂治疗一例。
Catheter Cardiovasc Interv. 2013 Dec 1;82(7):E884-7. doi: 10.1002/ccd.24797. Epub 2013 Aug 17.
9
Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome.慢性完全闭塞病变经皮冠状动脉介入治疗对左心室功能及临床结局影响的Meta分析
Int J Cardiol. 2015;187:90-6. doi: 10.1016/j.ijcard.2015.03.164. Epub 2015 Mar 17.
10
Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion.经皮血运重建慢性完全闭塞病变对临床结局的影响:比较慢性完全闭塞病变经皮介入治疗成功与失败的荟萃分析。
Catheter Cardiovasc Interv. 2013 Jul 1;82(1):95-107. doi: 10.1002/ccd.24863. Epub 2013 Mar 25.

引用本文的文献

1
Evaluating the Role of Allopurinol in Mitigating Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients: A Systematic Review and Meta-Analysis.评估别嘌醇在减轻经皮冠状动脉介入治疗患者造影剂肾病中的作用:一项系统评价和荟萃分析。
Cureus. 2024 Dec 25;16(12):e76374. doi: 10.7759/cureus.76374. eCollection 2024 Dec.
2
Impact of minimum contrast media volumes during percutaneous coronary intervention for chronic total occlusion lesion.经皮冠状动脉介入治疗慢性完全闭塞病变时最小对比剂用量的影响。
Heart Vessels. 2023 Sep;38(9):1108-1116. doi: 10.1007/s00380-023-02270-9. Epub 2023 Jun 13.
3
Efficacy of short-term moderate or high-dose statin therapy for the prevention of contrast-induced nephropathy in high-risk patients with chronic kidney disease: systematic review and meta-analysis.
短期中或高剂量他汀类药物治疗预防慢性肾脏病高危患者造影剂肾病的疗效:系统评价和荟萃分析。
Clinics (Sao Paulo). 2021 Mar 24;76:e1876. doi: 10.6061/clinics/2021/e1876. eCollection 2021.
4
Impact of Chronic Kidney Disease on Chronic Total Occlusion Revascularization Outcomes: A Meta-Analysis.慢性肾脏病对慢性完全闭塞病变血管重建结局的影响:一项荟萃分析。
J Clin Med. 2021 Jan 23;10(3):440. doi: 10.3390/jcm10030440.
5
Successful contemporary reverse controlled antegrade and retrograde subintimal tracking without contrast medium: a case report.无造影剂成功实施当代逆向控制顺行和逆行内膜下寻径术:病例报告
J Med Case Rep. 2018 Dec 27;12(1):390. doi: 10.1186/s13256-018-1918-2.
6
Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models.对比剂诱导的急性肾损伤啮齿动物模型的组织病理学评估
Biomed Res Int. 2016;2016:3763250. doi: 10.1155/2016/3763250. Epub 2016 Nov 16.
7
Percutaneous coronary intervention for chronic total occlusion improved prognosis in patients with renal insufficiency at high risk of contrast-induced nephropathy.经皮冠状动脉介入治疗慢性完全闭塞病变可改善造影剂肾病高危的肾功能不全患者的预后。
Sci Rep. 2016 Feb 22;6:21426. doi: 10.1038/srep21426.